We next explored the impact of targeting nuclear exporter protein XPO1 and Rho GTPase effector PAK4 either alone or in combination with lenvatinib in anaplastic thyroid cancer cells. This evidence concerns the gene PAK4 and thyroid gland undifferentiated (anaplastic) carcinoma.